17.06.2013 Views

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

EAU 2013 - Programme Book - YouMed

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Monday, 18 March - <strong>EAU</strong> <strong>Programme</strong><br />

Thematic Session 14<br />

11.00 - 12.00 Neurourology<br />

Blue Hall 1-2 - Level N1<br />

Chair: F.C. Burkhard, Berne (CH)<br />

11.00 - 11.15 State-of-the-art lecture Spinal cord injury: The initial management of the bladder<br />

G. Del Popolo, Florence (IT)<br />

Aims and objectives<br />

After spinal cord lesion we observe a period of spinal shock during which we must ensure the drainage of<br />

the bladder using an indwelling catheter, the bladder rehabilitation provide the removal of the indwelling<br />

catheter starting intermittent catheterisation. Further investigations are needed such as renal function tests,<br />

ultrasound, neurophysiological tests, urodynamic examination. Clinical and instrumental tests are mandatory<br />

to optimise rehabilitation management with the use of intermittent catheterism, conservative management,<br />

medical therapy and to prevent neurological bladder complications<br />

11.15 - 11.30 State-of-the-art lecture Pharmacotherapy for neurogenic bladder<br />

P. Radziszewski, Warsaw (PL)<br />

Aims and objectives<br />

The lecture will cover practical aspects of pharmacotherapy of different lower urinary tract conditions<br />

in patients with neurogenic bladder. The new compounds will be critically evaluated and guidelines on<br />

pharamacotherapy will be presented. The main focus will be on proper decision/treatment pathways and<br />

management of tolerability/efficay issues.<br />

11.30 - 11.45 State-of-the-art lecture Renal transplantation into a reconstructed bladder<br />

P. Lopez Pereira, Madrid (ES)<br />

Aims and objectives<br />

Not many years ago, patients with congenital abnormalities of the lower urinary tract or bladder dysfunction<br />

were denied Renal Transplant (RT) because they were considered very high risk recipients. However, in<br />

the last few decades we have learnt that in patients with low-capacity-poorly compliant bladders an<br />

Augmentation Cystoplasty (AC) will create a compliant low-pressure reservoir that will protect the kidney<br />

graft. The incidence of symptomatic UTI may be increased in transplanted patients with AC but UTI is more<br />

related with CIC non-compliance or VUR to the native kidneys than with the AC itself and usually does not<br />

lead to impairment of graft function. Today, patients with a bladder reconstruction can be transplanted with<br />

the same outcome (graft survival and function) as those with normal bladders, although the risk of malignant<br />

transformation in the augmented segment may be increased in these patients.<br />

11.45 - 12.00 Abstract presentations: Special selection from the poster sessions<br />

300 Desmopressin in the treatment of nocturia in patients affected by Parkinson’s disease<br />

S. Proietti, M. Gubbiotti, J.A. Rossi De Vermandois, A. Giannantoni (Rozzano, Perugia, Italy)<br />

441 Why anticholinergics fail: Oxybutynin and fesoterodine induce a shift from muscarinergic to purinergic<br />

transmission in the rat bladder<br />

P. Uvin, M. Boudes, J. Franken, A. Menigoz, S.J. Pinto, T. Gevaert, R. Verplaetse, J. Tytgat, R. Vennekens,<br />

T. Voets, D. De Ridder (Leuven, Belgium)<br />

<strong>EAU</strong> Milan <strong>2013</strong><br />

261<br />

Monday

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!